Citation Impact
Citing Papers
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
2007 StandoutScienceNobel
Mutant G-protein-coupled receptors as a cause of human diseases
2004
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Genetic Influences on Cystic Fibrosis Lung Disease Severity
2013
Molecular genetics of human hypertension
1998
Effects of Perceived Racism and Anger Inhibition on Ambulatory Blood Pressure in African Americans
2003
Molecular genetics of human hypertension
2000
Insights into α1 adrenoceptor function in health and disease from transgenic animal studies
2003
Reference values for exhaled nitric oxide (reveno) study
2006
Perceived discrimination and health: A meta-analytic review.
2009 Standout
Cystic fibrosis
2016 Standout
Cystic fibrosis
2003
Nucleotide signalling during inflammation
2014 StandoutNature
Regulation of Mast Cells by β-Agonists
2006
Descending control of pain
2002 Standout
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F e NO ) for Clinical Applications
2011 Standout
Pharmacogenetics of the human beta-adrenergic receptors
2006
Purinergic Signaling in the Airways
2012
Molecular Mechanisms of Human Hypertension
2001 Standout
Hypoxia and Inflammation
2011 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Hyperacidification in cystic fibrosis: links with lung disease and new prospects for treatment
2002
The PDZ Binding Motif of the β1 Adrenergic Receptor Modulates Receptor Trafficking and Signaling in Cardiac Myocytes
2002 StandoutNobel
Effects of Gender and Age at Diagnosis on Disease Progression in Long-term Survivors of Cystic Fibrosis
2010
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Racism as a Determinant of Health: A Systematic Review and Meta-Analysis
2015 Standout
Modifier genes and sickle cell anemia
2006
Regulation of G Protein-Coupled Receptor Kinases and Arrestins During Receptor Desensitization
2003 StandoutNobel
Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure
2011
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Fraction of Exhaled Nitric Oxide at 50 mL/s
2007
Endurance exercise performance: the physiology of champions
2007 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor
2010 StandoutNatureNobel
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Antithrombotic Therapy for VTE Disease
2012 Standout
The Rise and Fall of the Chemoattractant Receptor GPR33
2005 StandoutNobel
Polymorphisms of the β1-adrenergic receptor predict exercise capacity in heart failure
2002
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The development of allergic inflammation
2008 StandoutNature
The Third Intracellular Loop and the Carboxyl Terminus of β2-Adrenergic Receptor Confer Spontaneous Activity of the Receptor
2003 StandoutNobel
The structure and function of G-protein-coupled receptors
2009 StandoutNatureNobel
The immunology of stroke: from mechanisms to translation
2011 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Pediatric Idiopathic Intracranial Hypertension
2007
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
The Human Gene Map for Performance and Health-Related Fitness Phenotypes
2006
Sickle-cell disease
2010 Standout
The selectivity of β‐adrenoceptor agonists at human β1‐, β2‐ and β3‐adrenoceptors
2010
Differential Distribution of β-Adrenergic Receptor Subtypes in Blood Vessels of Knockout Mice Lacking β1-or β2-Adrenergic Receptors
2001 StandoutNobel
Antithrombotic Therapy in Neonates and Children
2012
Genetic Modifiers of Lung Disease in Cystic Fibrosis
2005
Structure of a β1-adrenergic G-protein-coupled receptor
2008 StandoutNatureNobel
2‐Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling
2002 StandoutNobel
Pediatric Idiopathic Intracranial Hypertension
2007
Atherosclerosis
2000 StandoutNature
Risk of Mortality and Heart Failure Exacerbations Associated With Inhaled β-Adrenoceptor Agonists Among Patients With Known Left Ventricular Systolic Dysfunctiona
2003
Exhaled Nitric Oxide in Pulmonary Diseases
2010
Lung disease modifier genes in cystic fibrosis
2014
Reference Ranges for Exhaled Nitric Oxide Derived from a Random Community Survey of Adults
2007
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation: A Comparison of Eculizumab Therapy and Conventional Therapy
2017
The selectivity of β‐adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors
2005
Nitric Oxide: A Key Mediator of Biofilm Dispersal with Applications in Infectious Diseases
2014
Inhaled l -Arginine Improves Exhaled Nitric Oxide and Pulmonary Function in Patients with Cystic Fibrosis
2006
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Primary Ciliary Dyskinesia
2003
Nitrogen Redox Balance in the Cystic Fibrosis Airway
2002
The Role and Regulation of Adenosine in the Central Nervous System
2001 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Stoichiometry and Compartmentation in G Protein-Coupled Receptor Signaling: Implications for Therapeutic Interventions Involving Gs
2000
Molecular Physiology of P2X Receptors
2002 Standout
The structural basis of g-protein-coupled receptor function and dysfunction in human diseases
2007
Mice lacking P2Y 2 receptors have salt‐resistant hypertension and facilitated renal Na + and water reabsorption
2007
Polymorphisms of the β1-adrenergic receptor predict exercise capacity in heart failure
2002
Pharmacogenetics and asthma: false hope or new dawn?: Table 1—
2007
Myocyte Adrenoceptor Signaling Pathways
2003 StandoutScienceNobel
Hypoxia-Inducible Factor 1 and Cardiovascular Disease
2013 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
HIF‐dependent induction of adenosine A2B receptor in hypoxia
2006
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children
2013 Standout
G protein-coupled receptor kinase 4 gene variants in human essential hypertension
2002
Phosphodiesterase 4D is required for β 2 adrenoceptor subtype-specific signaling in cardiac myocytes
2005 StandoutNobel
Distribution of α1-Adrenergic Receptor mRNA Species in Rat Heart
1998
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
Alpha1-adrenergic receptors: new insights and directions.
2001
Receptors for Purines and Pyrimidines
2012 Standout
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Hybrid Transgenic Mice Reveal In Vivo Specificity of G Protein–Coupled Receptor Kinases in the Heart
2000 StandoutNobel
What Is the Role of β-Adrenergic Signaling in Heart Failure?
2003
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
2012 StandoutNobel
Works of Rainer Büscher being referenced
beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease.
2002
P2Y2 receptor polymorphisms and haplotypes in cystic fibrosis and their impact on Ca2+ influx
2006
Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism
2009
In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans.
2001
Human adrenoceptor polymorphisms: evolving recognition of clinical importance
1999
Human adenosine 2B receptor: SNP discovery and evaluation of expression in patients with cystic fibrosis
2005
Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding
2010
Comparison of guinea‐pig, bovine and rat α1‐adrenoceptor subtypes
1996
2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans
2000
Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity
2018
Nasal Nitric Oxide Levels in Cystic Fibrosis Patients Are Associated with a Neuronal NO Synthase (NOS1) Gene Polymorphism
2002
Effects of Sex and of Gene Variants in Constitutive Nitric Oxide Synthases on Exhaled Nitric Oxide
2003
Endothelial Nitric Oxide Synthase Variants in Cystic Fibrosis Lung Disease
2003
Airway Nitric Oxide Levels in Cystic Fibrosis Patients Are Related to a Polymorphism in the Neuronal Nitric Oxide Synthase Gene
2000
Is α1D-adrenoreptor protein detactable in rat tissues?
1997
Blunted Cardiac Responses to Receptor Activation in Subjects With Thr164Ile β2-Adrenoceptors
2001
Pseudotumor cerebri following cyclosporine A treatment in a boy with tubulointerstitial nephritis associated with uveitis
2004
Ontogenesis of sympathetic responsiveness in spontaneously hypertensive rats. I. Renal alpha 1-, alpha 2-, and beta-adrenergic receptors and their signaling.
1993
Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders
2016
Variability in phenylephrine response and essential hypertension: a search for human alpha(1B)-adrenergic receptor polymorphisms.
1999